Heart & Lung: The Journal of Acute and Critical Care
Volume 36, Issue 4 , Pages 298-299 , July 2007

Ileostomy and ramipril-induced acute renal failure and shock

  • Jack P. Chen, MD, FACC, FSCAI, FCCP

      Affiliations

    • Corresponding Author InformationReprint requests: Jack P. Chen, 5670 Peachtree Dunwoody Road, # 880, Atlanta, GA 30342.

References 

  1. Smith CS, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. JACC. 2006;47:2130–2139
  2. Ross SD, Kasem SA, Zhang S, et al. Discontinuation of antihypertensive drugs due to adverse events: A systematic review and meta-analysis. Pharmacotherapy. 2001;21:940–953
  3. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145–153
  4. Braunwald E, Domanski MJ, Fowler SE, et al. PEACE Trial Investigators Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med. 2004;351:2058–2068
  5. Bloomgarden Z. Cardiovascular disease. Diabetes Care. 2006;29(5):1160–1166
  6. Kalantarinia K, Okusa MD. The renin-angiotensin system and its blockade in diabetic renal and cardiovascular disease. Curr Diabetes Rep. 2006;6(1):8–16
  7. Tropeano AI, Boutouyrie P, Pannier B, et al. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension. 2006;48(1):80–86
  8. Rosen AB. Indications for and utilization of ACE inhibitors in older individuals with diabetes (Findings from the National Health and Nutrition Examination Survey 1999 to 2002). J Gen Int Med. 2006;21(4):315–319
  9. Gaedeke J, Noble NA, Border WA. Angiotensin II and progressive renal insufficiency. Curr Hypertens Rep. 2002;4(5):403–407
  10. Coyne DW. Renal diseases. In:  Carey CF,  Lee HH,  Woeltje KF editor. The Washington Manual of Medical Therapeutics. 29th ed.. Philadelphia: Lippincott Williams and Wilkins; 1988;p. 27–43

PII: S0147-9563(06)00287-1

doi: 10.1016/j.hrtlng.2006.10.006

Heart & Lung: The Journal of Acute and Critical Care
Volume 36, Issue 4 , Pages 298-299 , July 2007

Article Tools